Institute for Medical Education and Research, Madelyn Trupkin Herzfeld, IMER, imer, imier, Miami, Florida, Nursing CE's, Nursing contact hours, nursing education, continuing education, medical research and education, Oncology, Postgraduate credit, oncology nurses, nurses, symposia, symposium, online educational credit, Breast Cancer, Cancer, cancer, breast cancer, colorectal cancer, Colorectal Cancer, Targeting EGFR, EGFR Inhibitors, egfr inhibitors, head and neck cancer, Anti-VEGF, VEGF Inhibitors, vegf inhibitors, lung cancer, head cancer, CINV, cinv, Chemotherapy Induced Nausea & Vomiting, chemotherapy, nausea, vomiting, mucositis, cancer pain, chronic pain  
 
  ONLINE CONTINUING EDUCATION PROGRAMS: RENAL CELL CARCINOMA
Multitargeted Agents for Therapeutically Challenging Tumors  

Managing the Complex Journey of Renal Cell Carcinoma

Description
The clinical development of monoclonal antibodies represents a major advancement in the treatment of patients with follicular NHL. In this educational symposium, the principles of antibody-based therapy will be described in 3-D video animation. This presentation will be followed by a historical review of follicular NHL treatment options and the current treatment landscape. An overview of how treatment decisions are made based on prognostic parameters will be given. A case presentation will facilitate discussions on the appropriate nursing management of patients with follicular NHL receiving monoclonal antibody therapy. Oncology nurses' understanding of presented issues and their own practice patterns will be questioned via audience response technology.

Audio/Visual

Release Date: October 2007
Expiration Date: October 2008
Estimated Time to Complete Activity: 1 hour 54 minutes
Credit Hours: 1.9

Program
Test/Evaluation
Questions?

Newsletter

Release Date: April 2008
Expiration: April 2009
Estimated Time to Complete Activity: 1 hour 54 minutes
 Credit Hours: 1.0

Newsletter (PDF)
Newsletter (HTML)
Test/Evaluation
Questions?

For Reference Only
Multitargeted Agents for Therapeutically Challenging Tumors  

Multitargeted Agents for Therapeutically Challenging Tumors: An Introduction for Oncology Nurses

Description
The emergence of multitargeted agents in oncology broadens the scope of targeted therapies for cancer patients. As these agents move into the arena of approved therapies, oncology nurses must understand their mechanisms of action, administration guidelines, potential toxicities, and how to provide adequate education to patients receiving them. In this educational program, recent clinical data on the incorporation of multitargeted agents into the treatment of two therapeutically challenging tumor types, gastrointestinal stromal tumor and renal cell carcinoma, will be presented along with information on the nursing management of patients receiving these novel agents.

Monograph

Monograph
Monograph (HTML)

     
More Coming Soon
     
 
 

Home | Mission | Philosophy | Clinical Team | Advisory Board | Services | Online CE |
Print CE | Symposia | Contact Info | Feedback | Employment Opportunities | Registration | Podcasts

© Copyright 2003 – 2008 Institute for Medical Education & Research, Inc. All Rights Reserved.